| Fecha de publicación | Título | Autor(es) |
| 2021 | Antiprotozoal compounds from Urolepis hecatantha (Asteraceae) | Elso, Orlando G; Clavin, Maria; Hernandez, Natalia; Sgarlata, Tomás; Bach, Hernán; Catalan, César A N; Aguilera, Elena; Álvarez, Guzmán; Sülsen, Valeria P |
| 2019 | Caenorhabditis elegans infrared-based motility assay identified new hits for nematicide drug development | Risi, Gastón; Aguilera, Elena; Ladós, Enrique; Suárez, Gonzalo; Carrera, Inés; Álvarez, Guzmán; Salinas, Gustavo |
| 2025 | Drug repurposing for Chagas disease: overcoming the hit-to-preclinical candidate stage | Veira, Claudia; Dávila Saralegui, Belén; Serna, Elva; Portillo, Nilda; Yaluff, Gloria; Álvarez, Guzmán; Cerecetto, Hugo; Aguilera, Elena |
| 2024 | Esperanza en la búsqueda del tratamiento para la Leishmaniasis visceral | Ramos, Rachel; Benítez, Diego; Comini, Marcelo A.; Álvarez, Guzmán; Aguilera, Elena |
| 2025 | Looking for approved-medicines to be repositioned as anti-Trypanosoma cruzi agents. Identification of new chemotypes with good individual- or in combination-biological behaviours | Veira, Claudia; Benítez, Diego; Pérez Díaz, Leticia; Álvarez, Guzmán; Cerecetto, Hugo; Aguilera, Elena |
| 2018 | Looking for combination of benznidazole and trypanosoma cruzitriosephosphate isomerase inhibitors for chagas disease treatment | Aguilera, Elena; Varela Ubillos, Javier Alejandro; Serna, Elva; Torres, Susana; Yaluff, Gloria; De Bilbao, Ninfa Vera; Cerecetto, Hugo; Álvarez, Guzmán; González, Mercedes |
| 2017 | Multi-anti-parasitic activity of arylidene ketones and thiazolidene hydrazines against trypanosoma cruzi and Leishmania spp. | Álvarez, Guzmán; Perdomo, Cintya; Coronel, Cathia; Aguilera, Elena; Varela, Javier; Aparicio Díaz, Hector Gonzalo; Zolessi, Flavio R.; Cabrera, Nallely; Vega, Celeste; Rolón, Miriam; Rojas de Arias, Antonieta; Pérez-Montfort, Ruy; Cerecetto, Hugo; González, Mercedes |
| 2019 | A nature-inspired design yields a new class of steroids against trypanosomatids | Aguilera, Elena; Perdomo, Cintya; Espíndola, Alejandra; Corvo, Ileana; Faral-Tello, Paula; Robello Porto, Carlos; Serna, Elva; Benítez, Fátima; Riveros, R.; Torres, Susana; Vera de Bilbao, N.I.; Yaluff, Gloria; Álvarez, Guzmán |
| 2025 | Novel potential drug scaffold against visceral Leishmaniasis discovered using a drug repurposing approach | Ramos, Rachel; Álvarez, Guzmán; Couto, Marcos; Comini, Marcelo A.; Benítez, Diego; Aguilera, Elena |
| 2024 | Polifarmacología como estrategia frente a la Leishmaniasis visceral y la Enfermadad de Chagas | Terra, Pilar; Veira, Claudia; Ramos, Rachel; Cerecetto, Hugo; Álvarez, Guzmán; Aguilera, Elena |
| 2023 | Preclinical studies and drug combination of low-cost molecules for Chagas disease | Aguilera, Elena; Sánchez, Carina; Cruces, María Eugenia; Dávila Saralegui, Belén; Minini Rivas, Lucía; Mosquillo, María Florencia; Pérez-Díaz, Leticia; Serna, Elva; Torres, Susana; Schini, Alicia; Sanabria, Luis; Vera de Bilbao, N.I.; Yaluff, Gloria; Zolessi, Flavio R.; Ceilas, Luis Fabian; Cerecetto, Hugo; Álvarez, Guzmán |
| 2021 | Preclinical studies in Anti-Trypanosomatidae drug development | Perdomo, Cintya; Aguilera, Elena; Corvo, Ileana; Faral-Tello, Paula; Serna, Elva; Robello Porto, Carlos; Wilkinson, Shane R.; Yaluff, Gloria; Álvarez, Guzmán |
| 2017 | Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent | Rodríguez, Gonzalo; Nargoli, Javier; López, Andrés; Moyna, Guillermo; Álvarez, Guzmán; Fernández, Marcelo; Osorio-Martínez, Carlos A; González, Mercedes; Cerecetto, Hugo |
